Prevalence and significance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma

Colorectal Disease

Volumn 15, Issue 1, 2013, Pages 52-56

  Walter, C J ^a   Bell, L T O ^b   Parsons, S R ^a   Jackson, C ^c   Borley, N R ^a   Wheeler, J M D ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Anaemia; Neoadjuvant chemoradiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; HEMOGLOBIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT CODING; PATIENT IDENTIFICATION; PREVALENCE; PRIORITY JOURNAL; RECTUM CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR REGRESSION;

ADENOCARCINOMA; AGED; ANEMIA; CHEMORADIOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871642102     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03112.x     Document Type: Article

References (24)

1. ACPGBI. Guidelines for the Management of Colorectal Cancer. (2007 2nd edition) http://www.acpgbi.org.uk/assets/documents/COLO_guides.pdf (accessed 28 December 2011).
2. Becker A, Stadler P, Lavey RRS et al. Severe anaemia is associated with poor tumour oxygenation in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2000; 46: 459-66.
3. Harrison LB, Chadra M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia on radiation therapy outcomes. Oncologist 2002; 7: 492-508.
4. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumours: roles of hypoxia and anaemia. Med Oncol 2001; 18: 243-9.
5. Overgaard J, Hansen HS, Andersen AP et al. Misinidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065-8.
6. Obermair A, Cheuk R, Horwood K et al. Impact of haemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 2001; 92: 903-8.
7. Robnett TJ, Machtay M, Hahn SM, Shrager JB, Friedberg JS, Kaiser LR. Pathological response to preoperative chemoradiation worsens with anaemia in non-small cell lung cancer patients. Cancer J 2002; 8: 263-7.
8. Box B, Lindsey I, Wheeler JM et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence and overall survival in nonanemic patients. Colorectal Dis 2005; 48: 1153-60.
9. Berardi R, Braconi C, Mantello G et al. Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer. Ann Oncol 2006; 17: 1661-4.
10. Lee SD, Park JW, Park KS et al. Influence of anaemia on tumour response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2009; 24: 1451-8.
11. Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database Syst Rev 2009; CD007148.
12. Lambin P, Ramaekers BLT, Van Mastrigt GAPG et al. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database Syst Rev 2009; CD006158.
13. Amato A, Pescatori M. Perioperative blood transfusions and the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006, Art. No.: CD005033. DOI: 10.1002/14651858.CD0050033.pub2.
14. Bohlius J, Schmidlin K, Brilliant C et al. Erythropoietin or darbepoetin for patients with cancer - meta-analysis based on individual patient data. Cochrane Database Syst Rev 2009, Art. No.: CD007303.DOI: 10.1002/14651858.CD007303.pub2.
15. Wheeler JMD, Warren BF, Mortensen NJ et al. Quantification of histologic regression of rectal cancer after irradiation. A proposal for a modified system. Dis Colon Rectum 2002; 45: 1051-6.
16. Wheeler JMD, Dodds E, Warrren BF et al. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade 2004. Dis Colon Rectum 2004; 47: 2025-31.
17. Hofheinz RD, Raab B, Mai S et al. Impact of chemoradiotherapy-induced anemia on survival in uniformly staged patients with locally advanced squamous cell carcinoma of the oesophagus. Onkologie 2004; 27: 462-6.
18. Kerr SF, Glynne-Jones R. Does pre-treatment haemoglobin influence the efficacy of pre-operative chemoradiotherapy (CRT) in rectal cancer?Colorectal Dis 2008; 10(S1): 26.
19. Lim CL, Kim JY, Kim TH et al. Allogenic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer. Yonsei Med J 2008; 49: 993-1003.
20. Leo c, Horn LC, Rauscher C et al. Expression of erythropoietin receptors in cervical cancer and relationship to survival, hypoxia, and apoptosis. Clin Cancer Res 2006; 12: 6894-900.
21. Dagnon K, Pacary E, Commo F et al. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. Clin Cancer Res 2005; 11: 993-9.
22. Aapro MS, Link H. September 2007 update on EORTC guidelines and anaemia management with erythropoiesis-stimulating agents. Oncologist 2008; 13(S3): 33-6.
23. Hoff CM, Hansen HS, Overgaard M et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy - results from the randomized DAHAHCA 5. Radiother Oncol 2011; 98: 28-33.
24. Bennett MH, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev 2005; CD005007.